Globally, an estimated 1.3 million women and girls living with HIV become pregnant every year, according to the World Health ...

Around 10 million people globally live with the life-threatening human T-cell lymphotropic virus type-1 (HTLV-1), yet it ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

AAV gene therapy in early life provides lasting HIV protection in primates—offering hope for pediatric HIV intervention in ...

Fort William First Nation members can be tested today for both HIV (human immunodeficiency virus) and HCV (hepatitis C) at a free community-based clinic.

Modupe O. Coker from the School of Dental Medicine and a collaborative team of researchers identified changes over time in ...

Resistance to ART was associated with poor clinical outcomes and increased economic burden in a national sample of veterans with HIV infection in the United States.

GSK tops Q2 estimates with growth in vaccines and specialty drugs, raises 2025 forecast amid progress in major late-stage ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Despite national commitments and visible progress in the fight against HIV/AIDS, Nigeria continues to grapple with high rate of paediatric HIV infections.Every year, more than 9,000 children in the ...